Ian Kitchen Selected Research

Ian Kitchen Research Topics

Disease

7	Pain (Aches) 01/2017 - 07/2002
5	Substance-Related Disorders (Drug Abuse) 01/2019 - 08/2012
3	Cocaine-Related Disorders (Cocaine Addiction) 09/2015 - 08/2012
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018 - 03/2014
2	Opioid-Related Disorders (Opiate Addiction) 01/2016 - 10/2004
1	Schizophrenia (Dementia Praecox) 01/2019
1	Anhedonia 10/2017
1	Catalepsy 01/2017
1	Chronic Pain 02/2015
1	Anxiety Disorders (Anxiety Disorder) 02/2015
1	Mood Disorders (Mood Disorder) 03/2014
1	Tobacco Use Disorder (Nicotine Dependence) 10/2010
1	Cardiotoxicity 01/2009
1	Body Weight (Weight, Body) 04/2008
1	Seizures (Absence Seizure) 04/2007

Drug/Important Bio-Agent (IBA)

9	Opioid Analgesics (Opioids)IBA 01/2016 - 07/2002
4	Oxytocin (Pitocin)FDA LinkGeneric 01/2019 - 03/2014
4	Adenosine (Adenocard)FDA LinkGeneric 06/2007 - 07/2002
3	Nicotine FDA Link 01/2019 - 10/2010
3	Cocaine (Cocaine HCl)IBA 09/2015 - 01/2009
2	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2019 - 09/2015
2	Peptides (Polypeptides)IBA 01/2019 - 03/2014
2	CorticosteroneIBA 10/2017 - 03/2014
2	Heroin (Diamorphine)IBA 01/2017 - 04/2013
2	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2017 - 07/2002
2	NeuropeptidesIBA 10/2016 - 04/2014
2	Metabotropic Glutamate 5 ReceptorIBA 01/2016 - 09/2015
2	Opioid Receptors (Opioid Receptor)IBA 09/2015 - 04/2007
1	MecamylamineIBA 01/2018
1	Sucrose (Saccharose)IBA 10/2017
1	Imipramine (Janimine)FDA LinkGeneric 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2017
1	Anti-Anxiety Agents (Anxiolytics)IBA 02/2015
1	delta Opioid Receptors (delta Opioid Receptor)IBA 02/2015
1	Opioid Peptides (Opioid Peptide)IBA 08/2012
1	TOPSIBA 08/2012
1	Cholinergic Agents (Cholinergics)IBA 10/2010
1	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 01/2009
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2009
1	NADP (NADPH)IBA 01/2009
1	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 01/2009
1	AntioxidantsIBA 01/2009
1	dihydroethidiumIBA 01/2009
1	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 04/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2007
1	DiprenorphineIBA 04/2007
1	NAD (NADH)IBA 04/2007
1	TachykininsIBA 08/2005
1	Analgesics (Analgesic Drugs)IBA 07/2002
1	Morphine (MS Contin)FDA LinkGeneric 07/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2016 - 08/2012
1	Secondary Prevention 08/2012
1	Therapeutics 01/2009
1	Intraperitoneal Injections 04/2008